Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    WNT11
Show Display Options
Rank Status Study
1 Completed
Has Results
TORPEDO Study: A Study on Rapid Effect of Tocilizumab in Patients With Rheumatoid Arthritis With an Inadequate Response to Disease-Modifying Antirheumatic Drugs (DMARDs) or Anti-TNF
Condition: Rheumatoid Arthritis
Interventions: Drug: tocilizumab [RoActemra/Actemra];   Drug: placebo
2 Recruiting First in Man Study Investigating the Biodistribution, the Safety and Optimal Recommended Dose of a New Radiolabelled Monoclonal Antibody Targeting Frizzled Homolog 10
Condition: Sarcoma, Synovial
Interventions: Drug: OTSA101-DTPA-90Y level 1;   Drug: OTSA101-DTPA-90Y level 2;   Drug: OTSA101-DTPA-90Y level 3

Indicates status has not been verified in more than two years